Quanhai Liu, Jiawei Lai, Jiancang Ma, Fangshi Xu
Amador-Martínez I, Aranda-Rivera AK, Martínez-Castañeda MR, Pedraza-Chaverri J. Mitochondrial quality control and stress signaling pathways in the pathophysiology of cardio-renal diseases. Mitochondrion. 2025;84:102040. Google Scholar Wang D, Li Y, Li G, Liu M, Zhou Z, Wu M, et al. Inhibition of PKC-δ retards kidney fibrosis via inhibiting cGAS-STING signaling pathway in mice. Cell Death Discov. 2024;10:314. Google Scholar Fu W, Wang J, Li T, Qiao Y, Zhang Z, Zhang X, et al. Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat Chem Biol. 2025;21:1238–49. Liu F, Yang Z, Li J, Wu T, Li X, Zhao L, et al. Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy. Mol Med. 2024;30:265. Google Scholar Guo Y, Che R, Wang P, Zhang A. Mitochondrial dysfunction in the pathophysiology of renal diseases. Am J Physiol: Ren Physiol. 2024;326:F768–f79. Google Scholar Tang C, Cai J, Yin XM, Weinberg JM, Venkatachalam MA, Dong Z. Mitochondrial quality control in kidney injury and repair. Nat Rev Nephrol. 2021;17:299–318. Google Scholar Wang Y, Zeng Y, Fu Y, Liu Z, Hu X, Tang C, et al. Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair. Kidney Int. 2025;107:869–87. Google Scholar Doke T, Susztak K. The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development. Trends Cell Biol. 2022;32:841–53. Google Scholar Bauer TM, Murphy E. Role of mitochondrial calcium and the permeability transition pore in regulating cell death. Circ Res. 2020;126:280–93. Google Scholar Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19:401–14. Google Scholar Thompson AD, Victor Santiago Raj P, Scholpa NE, Schnellmann RG. Repurposing mitochondria-targeted therapeutics for kidney diseases. Kidney Int. 2025;107:617–27. Google Scholar Hu H, Ji R, Hao Y, Liu Z, Yang J, Cao Y, et al. XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease. Autophagy. 2026;22:207–28. Google Scholar Hsu SN, Stephen LA, Phadwal K, Dillon S, Carter R, Morton NM, et al. Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder. Kidney Int. 2025;107:1017–36. Aqeel A, Akram A, Ali M, Iqbal M, Aslam M, Rukhma Shah FI. Mechanistic insights into impaired β-oxidation and its role in mitochondrial dysfunction: a comprehensive review. Diab Res Clin Pract. 2025;223:112129. Google Scholar Ravindran R, Gustafsson ÅB. Mitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing. Nat Rev Cardiol. 2025;22:798–813. Kageyama Y, Okura S, Sukigara A, Matsunaga A, Maekubo K, Oue T, et al. The association among bipolar disorder, mitochondrial dysfunction, and reactive oxygen species. Biomolecules. 2025;15:383. Google Scholar Bochkova ZV, Baizhumanov AA, Yusipovich AI, Morozova KI, Nikelshparg EI, Fedotova AA, et al. The flexible chain: regulation of structure and activity of ETC complexes defines rate of ATP synthesis and sites of superoxide generation. Biophys Rev. 2025;17:55–88. Google Scholar An X, Yu W, Liu J, Tang D, Yang L, Chen X. Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis. 2024;15:556. Google Scholar Ye K, Lan R, Chen Z, Lai K, Song Y, Li G, et al. Roles of ACSL4/GPX4 and FSP1 in oxalate-induced acute kidney injury. Cell Death Discov. 2025;11:279. Google Scholar Wang J, Luo H, He Q, Shao H, Cai X, Cao Y, et al. NCOA7 inhibits renal cancer progression by inducing autophagy and lipid metabolism through V-ATPase interaction. Cell Death Discov. 2025;11:471. Google Scholar Yan J, Bengtson CP, Buchthal B, Hagenston AM, Bading H. Coupling of NMDA receptors and TRPM4 guides discovery of unconventional neuroprotectants. Science. 2020;370:eaay3302. Google Scholar DiPolo R, Beaugé L. Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions. Physiol Rev. 2006;86:155–203. Google Scholar Chavda V, Lu B. Reverse electron transport at mitochondrial complex I in ischemic stroke, aging, and age-related diseases. Antioxidants. 2023;12:895. Google Scholar Glaser KB, Mobilio D, Chang JY, Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci. 1993;14:92–8. Google Scholar Pham L, Arroum T, Wan J, Pavelich L, Bell J, Morse PT, et al. Regulation of mitochondrial oxidative phosphorylation through tight control of cytochrome c oxidase in health and disease - Implications for ischemia/reperfusion injury, inflammatory diseases, diabetes, and cancer. Redox Biol. 2024;78:103426. Google Scholar Li C, Yu Y, Zhu S, Hu Y, Ling X, Xu L, et al. The emerging role of regulated cell death in ischemia and reperfusion-induced acute kidney injury: current evidence and future perspectives. Cell Death Discov. 2024;10:216. Google Scholar Chen M, Simard JM. Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain. J Neurosci Off J Soc Neurosci. 2001;21:6512–21. Google Scholar Leiva-Salcedo E, Riquelme D, Cerda O, Stutzin A. TRPM4 activation by chemically- and oxygen deprivation-induced ischemia and reperfusion triggers neuronal death. Channels. 2017;11:624–35. Google Scholar Gerzanich V, Woo SK, Vennekens R, Tsymbalyuk O, Ivanova S, Ivanov A, et al. De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med. 2009;15:185–91. Google Scholar Li CSZ, Yu B, Gao Q, Dong HL, Li ZL. The critical role of ion channels in kidney disease: perspective from AKI and CKD. Ren Fail. 2025;47:2488139. Google Scholar Girardi ACC, Polidoro JZ, Castro PC, Pio-Abreu A, Noronha IL, Drager LF. Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions. Am J Physiol Cell Physiol. 2024;327:C525–c44. Google Scholar Chen B, Gao Y, Wei S, Low SW, Ng G, Yu D, et al. TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke. Pflug Arch Eur J Physiol. 2019;471:1455–66. Google Scholar Zhao HJ, Li Y, Liu SM, Sun XG, Li M, Hao Y, et al. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis. Ren Fail. 2016;38:849–56. Google Scholar Tsien RW, Ellinor PT, Horne WA. Molecular diversity of voltage-dependent Ca2+ channels. Trends Pharmacol Sci. 1991;12:349–54. Google Scholar Tian Y, Zheng J. The TRP channels serving as chemical-to-electrical signal converter. Physiol Rev. 2025;105:1033–74. Google Scholar Ullrich ND, Voets T, Prenen J, Vennekens R, Talavera K, Droogmans G, et al. Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium. 2005;37:267–78. Google Scholar Sica D. Calcium channel blockers and the kidney. Clin Cornerstone. 2004;6:39–52. Google Scholar Yu B, Jin L, Yao X, Zhang Y, Zhang G, Wang F, et al. TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy. Theranostics. 2023;13:4356–75. Google Scholar Ekundayo B, Arullampalam P, Gerber CE, Hämmerli AF, Guichard S, Boukenna M, et al. Identification of a binding site for small molecule inhibitors targeting human TRPM4. Nat Commun. 2025;16:833. Google Scholar Download references